関連する実験動画
Updated: Mar 27, 2026

09:03
Manufacture and Drug Delivery Applications of Silk Nanoparticles
Published on: October 8, 2016
16.8K
薬物の配達における新たな境界線
Mark W Tibbitt1,2, James E Dahlman3,4, Robert Langer1,2,5
1Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology , Cambridge, Massachusetts 02142, United States.
Journal of the American Chemical Society
|January 8, 2016
まとめ
薬剤の有効な投与は,治療の成功に不可欠であり,薬理動力学と毒性に影響を与える. 材料科学の進歩により 臨床的成果を向上させるため 系統的RNA,局所的,経口,および生物学的薬剤投与における障壁を克服しています
科学分野:
- 材料科学
- 薬理学について
- バイオテクノロジー
背景:
- 薬剤の有効性は,投与経路によって決定され,薬理学,分布,代謝,および毒性に影響する.
- 生物学的薬のような新興治療は 標的を絞った投与と 持続的な治療用濃度のための 先進的な薬剤投与システムを必要とします
研究 の 目的:
- 薬物の投与と制御された放出に関する歴史的概要を提示する.
- 4つの重要な新興分野における進歩を強調する
- 臨床効果のための障壁と化学/材料の解決策を特定する.
主な方法:
- 薬剤の投与と制御された放出の原則の歴史的レビュー
- 新興薬剤投与領域の分析:全身RNA,局所療法,口腔および生物学的システム.
- 各分野における課題と物質的なイノベーションの特定
主要な成果:
- 薬物投与は治療結果と体内の薬物行動に大きな影響を与えます
- 重要な新興分野には,全身RNA,局所的,経口,および生物学的薬物投与が含まれています.
- 化学と材料科学のイノベーションは,供給の障壁を克服するために不可欠です.
結論:
- 治療効果を最大化し 副作用を最小限に抑えるには 薬剤投与システムを最適化することが不可欠です
- 薬物投与技術の進歩には,材料と化学の継続的なイノベーションが不可欠です.
- 新薬の臨床効果を高めるために 課題を解決する
関連する概念動画
Drug Delivery: Overview
1.1K
The selection of a drug's delivery route depends upon its physicochemical properties, including lipid or water solubility and ionization, as well as the therapeutic requirement, such as immediate or sustained effect. These routes can be divided into three primary categories: enteral, parenteral, and topical.
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...
1.1K
Drug Delivery Systems: Different Types
235
Conventional oral drug products, termed immediate-release (IR) formulations, are engineered to promptly release their active pharmaceutical ingredient (API) upon ingestion, typically in tablets or capsules. This rapid release often results in swift drug absorption and consequent pharmacodynamic effects, although the timing and intensity can vary depending on the drug's properties. Prodrugs within these formulations require metabolic conversion to activate their pharmacodynamic effects,...
235
Oral Drug Delivery Systems: Introduction
209
Oral drug delivery is the most common route of administration due to its convenience, cost-effectiveness, and high patient compliance. It enables precise formulation to ensure proper drug dosage and bioavailability. The development of oral dosage forms considers drug properties such as solubility, stability, and absorption to optimize therapeutic efficacy.Tablets, capsules, liquids, and chewable formulations enhance drug stability, mask undesirable tastes, and improve patient experience.
209
Drug Delivery: Miscellaneous Routes
967
Drug delivery methods like oral inhalation, nasal sprays, transdermal patches, eye drops, intravitreal injection, and rectal administration provide localized effects with reduced toxicity.
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
967
Site-Targeted Drug Delivery Systems: Polymeric Carriers
109
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
109
Modified-Release Drug Delivery Systems: Overview
152
Modified-release dosage forms are designed to address the limitations of drugs with short biological half-lives. These forms maintain stable therapeutic drug concentrations over extended periods, reducing the need for frequent dosing. A consistent drug level helps minimize peak-trough fluctuations, which can reduce adverse effects, lower the risk of drug resistance, and improve overall treatment effectiveness.One common type of modified-release form is the extended-release (ER) formulation. ER...
152

